{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05201014",
            "orgStudyIdInfo": {
                "id": "21-006790"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2022-05920",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trials Reporting Program)"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Cancer Survivor Cardiomyopathy Detection",
            "officialTitle": "CAncer Survivor CArdiomyopathy DEtection Pilot Study",
            "acronym": "CASCADE",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "cancer-survivor-cardiomyopathy-detection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-10-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-02",
            "studyFirstSubmitQcDate": "2022-01-19",
            "studyFirstPostDateStruct": {
                "date": "2022-01-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Joerg Herrmann, MD",
                "investigatorTitle": "Professor of Medicine",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Miami Heart Research Institute",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.",
            "detailedDescription": "The primary objective of this study is to define the diagnostic performance and optimal cutoffs of AI-ECG and NT-pro-BNP for the detection of left ventricular dysfunction (LVD, defined as a left ventricular ejection fraction (LVEF) \\<50%) in cancer patients at 1 year after completion of anthracycline-based chemotherapy."
        },
        "conditionsModule": {
            "conditions": [
                "Cardiovascular Diseases",
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_ONLY",
                "timePerspective": "OTHER"
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "1 year follow-up",
                    "description": "patients who were treated in the year before and are now returning for their 1-year follow-up.",
                    "interventionNames": [
                        "Diagnostic Test: NT-pro-BNP",
                        "Diagnostic Test: Electrocardiogram",
                        "Diagnostic Test: Echocardiogram"
                    ]
                },
                {
                    "label": "Prior to anthracycline-based therapy",
                    "description": "patients presenting before the start of anthracycline-based therapy, then to be followed thereafter for 1 year and thereby contributing to the pool of patients with 1-year post-anthracycline assessment.",
                    "interventionNames": [
                        "Diagnostic Test: NT-pro-BNP",
                        "Diagnostic Test: Electrocardiogram",
                        "Diagnostic Test: Echocardiogram"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "NT-pro-BNP",
                    "description": "Blood draw",
                    "armGroupLabels": [
                        "1 year follow-up",
                        "Prior to anthracycline-based therapy"
                    ],
                    "otherNames": [
                        "Blood Biomarker"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Electrocardiogram",
                    "description": "electrodes are placed on certain spots and a reading obtained to measure the voltage of the heart",
                    "armGroupLabels": [
                        "1 year follow-up",
                        "Prior to anthracycline-based therapy"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Echocardiogram",
                    "description": "medical imaging of the heart",
                    "armGroupLabels": [
                        "1 year follow-up",
                        "Prior to anthracycline-based therapy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Diagnostic performance of AI-ECG for left ventricular ejection fraction (LVEF) < 50%",
                    "description": "Determination of the sensitivity, specificity, positive and negative prediction value as well as area under the curve for receiver operating characteristics for the 12-lead AI ECG algorithm for an LVEF \\<50%",
                    "timeFrame": "1 year post anthracycline therapy"
                },
                {
                    "measure": "Diagnostic performance of NT-pro-BNP for left ventricular ejection fraction (LVEF) < 50%",
                    "description": "Determination of the sensitivity, specificity, positive and negative prediction value as well as area under the curve for receiver operating characteristics for NT-pro-BNP \\>125 for an LVEF \\<50%",
                    "timeFrame": "1 year post anthracycline therapy"
                },
                {
                    "measure": "Diagnostic performance of AI-ECG and NT-pro-BNP for left ventricular ejection fraction (LVEF) < 50%",
                    "description": "Determination of the sensitivity, specificity, positive and negative prediction value as well as area under the curve for receiver operating characteristics for the 12-lead AI ECG algorithm and NT-pro-BNP \\>125 combined for an LVEF \\<50%",
                    "timeFrame": "1 year post anthracycline therapy"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Absolute change in LVEF from baseline to 1 year from anthracycline-based therapy",
                    "description": "Calculation of the the change in LVEF from baseline to 1 year from anthracycline-based therapy",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Absolute change in AI-ECG probability for LVEF <50% from baseline to 1 year from anthracycline-based therapy",
                    "description": "Calculation of the change in AI-ECG probability of LVEF \\<50% from baseline to 1 year from anthracycline-based therapy",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Correlation of change in LVEF and AI-ECG probability of LVEF <50% from baseline to 1 year from anthracycline-based therapy",
                    "description": "Calculation of the correlation coefficient of change in LVEF and AI-ECG probability of LVEF \\<50% from baseline to 1 year from anthracycline-based therapy",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Absolute change in NT-pro-BNP from baseline to 1 year from anthracycline-based therapy",
                    "description": "Calculation of the change NT-pro-BNP from baseline to 1 year from anthracycline-based therapy",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Correlation of change in LVEF and NT-pro-BNP from baseline to 1 year from anthracycline-based therapy",
                    "description": "Calculation of the correlation coefficient of change in LVEF and NT-pro-BNP from baseline to 1 year from anthracycline-based therapy",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226518 years of age prior to enrollment and anthracycline start date\n* diagnosis of breast cancer, lymphoma, or sarcoma with either planned or at 1 year after completion of anthracycline therapy, including patients from 6-12 months and greater than 1 year post-anthracycline exposure.\n\nExclusion Criteria:\n\n* LVEF \\<50% or prior confirmed history of cardiomyopathy, heart failure, persistent atrial fibrillation, left bundle branch block, or paced rhythm\n* Individuals with pacemakers, defibrillators, or other implanted electronic devices\n* Inability/unwillingness of individual to give written informed consent",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "200 cancer survivors who are 1 year out from anthracycline-based therapy.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tiffany Hansen",
                    "role": "CONTACT",
                    "phone": "507-293-0196",
                    "email": "Hansen.Tiffany@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Joerg Herrmann, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015",
                            "email": "mayocliniccancerstudies@mayo.edu"
                        },
                        {
                            "name": "Tiffany Hansen",
                            "role": "CONTACT",
                            "phone": "507-293-0196",
                            "email": "Hansen.Tiffany@mayo.edu"
                        },
                        {
                            "name": "Joerg Herrmann, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}